GlassScriptPhysician profile
Sarada Jaimungal
NPI 1104055227
$1,790.69
in general payments reported to CMS, 2019-2025
19 companies · $524 in 2025
The $524 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $860 · 2020: $165 · 2021: $60.16 · 2022: $20.01 · 2023: $14.32 · 2024: $148 · 2025: $524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $601 · Gift: $42.50 · Education: $42.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $601.15 |
| Gift | $42.50 |
| Education | $42.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $408.92 | 2019-2025 | Zepbound |
| Novo Nordisk INC | $252.13 | 2019-2025 | Ozempic |
| Sanofi-Aventis U.S. LLC | $217.00 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $186.84 | 2019-2020 | |
| Mannkind Corporation | $152.89 | 2020-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $146.19 | 2019 | |
| Inspire Medical Systems, INC. | $118.94 | 2025 | Inspire |
| Amgen INC. | $63.44 | 2019 | |
| Corcept Therapeutics | $44.85 | 2020-2022 | |
| Horizon Therapeutics Plc | $37.43 | 2019 | |
| Shire North American Group INC | $28.56 | 2019 | |
| Janssen Pharmaceuticals, INC | $26.27 | 2019 | |
| Merck Sharp & Dohme LLC | $22.60 | 2020 | |
| Abbott Laboratories | $15.33 | 2019 | |
| Amarin Pharma, INC. | $15.08 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $14.93 | 2019 | |
| Hologic Sales and Service, LLC | $14.32 | 2023 | Coolseal Generator |
| Dexcom, INC. | $13.83 | 2020 | |
| Eisai INC. | $11.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarada Jaimungal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.